Cambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2023-02-13_um_09.42.45.png366713Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-13 09:24:042024-04-04 16:44:47Cydar Medical Ltd raises €10.5m in Series A financing
British Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital.
https://european-biotechnology.com/wp-content/uploads/2024/04/evonteix-home-silicon-array.jpeg571800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-07 17:13:432024-07-15 12:58:38Evonetix extends Series B financing to US$54m
Toulouse White Biotech (TWB) is a good example to how scaling and collaboration through production partnerships can help the industrial biotech sector to satisfy the urgent need to speed up and scale sustainable processes for industrial production.
https://european-biotechnology.com/wp-content/uploads/2024/04/Christian_Bo__hm.jpg16001600Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-07 11:46:002024-04-02 16:19:47TWB, an original model supporting the bioeconomy
https://european-biotechnology.com/wp-content/uploads/2024/04/Vetter_Supporting_efficient_drug_development_with_dedicated_clinical_development_expertise_Vial_Filling1-scaled.jpg18542560Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-06 16:32:392024-04-02 15:34:24Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Dr Carole Nicco took up her position as CSO of Belgium-based BioSenic in mid-January. Nicco will oversee the development of BioSenic’s cell therapy and autoimmune disease platform pipeline and be responsible for R&D programmes.
https://european-biotechnology.com/wp-content/uploads/2024/04/Eb.com_Carole_Nicco_kl.jpg718639Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-02-06 13:26:002024-07-16 17:26:08BioSenic strengthens scientific team with new CSO
https://european-biotechnology.com/wp-content/uploads/2024/04/EMA-building.jpg10801920Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-06 12:13:062024-07-15 12:50:48New EU stakeholder platform to speed up clinical trials
HOOKIPA bags US$10m cancer milestone
Latest NewsHOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers.
Cydar Medical Ltd raises €10.5m in Series A financing
Latest NewsCambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust
Upping sustainability in pharma packaging
Latest NewsHow to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023.
Evonetix extends Series B financing to US$54m
Latest NewsBritish Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital.
TWB, an original model supporting the bioeconomy
BackgroundToulouse White Biotech (TWB) is a good example to how scaling and collaboration through production partnerships can help the industrial biotech sector to satisfy the urgent need to speed up and scale sustainable processes for industrial production.
Germany’s Curevac offers common shares
Latest NewsmRNA vaccine pioneer CureVac N.V. has announced that it will sell US$200m of its common shares in an underwritten public offering.
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Sponsored PublicationsBoth the US Skokie and European Rankweil sites address customer needs in early-phase drug development
BioSenic strengthens scientific team with new CSO
AppointmentsDr Carole Nicco took up her position as CSO of Belgium-based BioSenic in mid-January. Nicco will oversee the development of BioSenic’s cell therapy and autoimmune disease platform pipeline and be responsible for R&D programmes.
Chong Kun Dang Pharm licences Synaffix ADC platform
Latest NewsSouth Korean Chong Kun Dang Pharm has licenced access to Amsterdam-based Synaffix BV’s propietary ADC platform.
New EU stakeholder platform to speed up clinical trials
Latest NewsA new platform is set to facilitate the exchange of information on the optimisation of the electronic reporting system CTIS.